Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1364 results

Valve-in-valve TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.

Valve-in-valve TAVI

TAVI and coronary artery disease

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.

TAVI and coronary artery disease

Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis

24 Sep 2021

Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Patrick M. Looser

Reviewer

Patrick M. Looser
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis

Planning for the Future: Lifetime Management Considerations for TAVI Patients

23 Sep 2021 – From PCR Tokyo Valves 2021

By establishing a constant parallel between the situation in the United States and that in Japan, based on data collected daily, Jeffrey Popma and Shinichi Shirai provide current insights into the use of the soft expanding supra-annular evolution platform. In particular, they address the question of which patient...

Planning for the Future: Lifetime Management Considerations for TAVI Patients

Optimizing TAVI Procedures: Is Cusp Overlap Standard of Care?

23 Sep 2021 – From PCR Tokyo Valves 2021

Based on the results of the Optimize PRO and OCEAN-TAVI studies, Yohei Ohno and Yusuke Watanabe explain the key principles of the cusp overlap technique, a novel technique to potentially reduce new onset conduction disturbance. The objectives of the cusp overlap technique being to Determine, Assess, Reduce, and...

Optimizing TAVI Procedures: Is Cusp Overlap Standard of Care?

My implantation technique to minimize PPI

20 Sep 2021 – From PCR Tokyo Valves 2021

Watch this interview of Lars Søndergaard to understand why cusp overlap view tends to take the fold on the traditional technique of the three-cusp view to reduce risk of conduction subnormality, especially in young patients. Since the approval of TAVI in Europe in 2007, there has...

My implantation technique to minimize PPI

PCR-TV: reducing permanent pacemaker implantation post-TAVR: tips & tricks

15 Sep 2021

In this video, Kuljit Singh, Anthony Camuglia and Ganesh Manoharan discuss both the Cusp overlap technique as a way to reduce permanent pacemaker implantation post transcatheter aortic valve replacement (TAVR) and the frame alignment technique to optimise TAV implantation.

PCR-TV Reducing permanent pacemaker implatations post TAVR

Post-dilation from contralateral access site for nose cone entrapment during self-expandable transcatheter aortic valve implantation

07 Sep 2021

View this successful case with bail-out post-dilation for modifying nose cone entrapment due to stent frame infolding.

Post-dilation from contralateral access site for nose cone entrapment during self-expandable transcatheter aortic valve implantation

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

2021 ESC/EACTS Valvular Heart Disease Guidelines: interview with Alec Vahanian

29 Aug 2021

Mirvat Alasnag interviews Alec Vahanian on the Essentials of the 2021 ESC/EACTS Guidelines on Valvular Heart Diseases.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Dr. Alec Vahanian

Author

Alec Vahanian
ESC 2021 - Valvular Heart Disease Guidelines

ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines

29 Aug 2021

There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag

PCRonline @ ESC Congress 2021: the interventional cardiology perspective!

21 Jul 2021

Make sure you stay up to date with what's new and hot in interventional cardiology at this year's #ESCCongress!

PCRonline @ ESC Congress 2021

Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement

09 Jul 2021

Read more about the Nordic Aortic Valve Intervention (NOTION) trial to compare clinical outcomes and durability of bioprosthetic aortic valves 8 years after TAVI and SAVR.

Reviewer

Salvatore Brugaletta
Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement

#2 - How can I minimise paravalvular leak for my TAVI patients?

29 Jun 2021

Watch this PCR Webinar with A. Latib, M. Reardon and L. Sondergaard

How can I minimise paravalvular leak for my TAVI patients?

Discover the new Evolut­™ PRO+ TAVI System

17 Jun 2021

New data from Optimize PRO interim analysis

From a design built on a proven platform1, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.

Discover the new Evolut™ PRO+ TAVI System

Moderate aortic stenosis in patients with heart failure and reduced ejection fraction

08 Jun 2021

The aim of this study was to determine the prognostic impact conferred by the presence of moderate AS on the outcomes of patients with HFrEF.

Luigi Biasco

Reviewer

Luigi Biasco
Moderate aortic stenosis in patients with heart failure and reduced ejection fraction

Navitor™ – A new TAVI solution: highlights from EuroPCR 2021

03 Jun 2021

Watch these sessions on Navitor™, a new TAVI solution and learn more about what G. Manoharan, H. Möllmann, L. Søndergaard and D. Smith shared during EuroPCR 2021.

Navitor™ – A new TAVI solution: highlights from EuroPCR 2021

EuroPCR 2021 Hotlines / Late-Breaking Trials: STS-ACC TVT Registry, AMTRAC, MATCH-BALL, SWENTRY, and ITAL-neo Registry

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in TAVI:

  • STS/ACC TVT Registry: TAVR for bicuspid aortic valve stenosis in low surgical risk population
  • AMTRAC Valve Registry: regression of mitral regurgitation and outcomes following TAVR
  • MATCH-BALL study: matched comparison of outcomes with Balloon-Expandable transcatheter heart valve
  • SWENTRY registry: radiological predictors...
EuroPCR 2021 Hotlines / Late-Breaking Trials: STS-ACC TVT Registry, AMTRAC, MATCH-BALL, SWENTRY, and ITAL-neo Registry

EuroPCR 2021 Hotlines / Late-Breaking Trials: SWENTRY, Redo-TAVI, Early neo2, PORTICO NG, and Evolut Low Risk Trial

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in TAVI:

  • SWENTRY registry, Swedish Stroke Registry and National Patient Registry: late stroke after TAVI
  • Redo-TAVI registry: implantation of a supplementary transcatheter aortic valve during TAVI
  • Acurate neo2 TAVI valve results from the Early neo2 registry
  • PORTICO NG: 30-day outcomes from a...
EuroPCR 2021 Hotlines / Late-Breaking Trials: SWENTRY, Redo-TAVI, Early neo2, PORTICO NG, and Evolut Low Risk Trial

EuroPCR 2021 Jon DeHaan Foundation Award

20 May 2021 – From EuroPCR 2021

View a replay of the Jon DeHaan Foundation Award Ceremony, during which David Kuraguntla and Domenico D’Amario receive rewards for their innovative developments in cardiovascular medicine!

Learn more about the Jon DeHaan Foundation: https://www.jondehaanfoundation.org/

This session was originally presented during EuroPCR 2021.

EuroPCR 2021 - Jon DeHaan Foundation Award